✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
Complaints disappeared in both cases after the end of therapy course without any change in doses.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Complaints of impotance appeared in the first month of treatment in two cases receiving interferon $alpha$ 2a for chronic active hepatitis B infection.
📊
Key Findings & Data:Complaints of impotance appeared in the first month of treatment in two cases receiving interferon $alpha$ 2a for chronic active hepatitis B infection.
💡
Conclusion & Impact:Complaints disappeared in both cases after the end of therapy course without any change in doses.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Complaints of impotance appeared in the first month of treatment in two cases receiving interferon $alpha$ 2a for chronic active hepatitis B infection. Complaints disappeared in both cases after the end of therapy course without any change in doses.
Özet
Kronik aktif hepatit B tanısıyla interferon- $alpha$ 2a tedavisi uygulanan iki olguda, tedavinin birinci ayında impotans yakınması ortaya çıktı. Doz değiştirilmeksizin sürdürülen altı aylık tedavi süresinin bitiminde her iki hastanın yakınmaları gerileyerek kayboldu.
🔖
Cite This Article
USLUER, G., ÇOLAK, H., ÖZGÜNEŞ, İ., DEMİRTÜRK, N. (2022). İnterferon- $alpha$ 2a induced impotance in two patients. İnfeksiyon Dergisi, Cilt: 12 - Sayı: 1, 109–111. https://ajindex.com/articles/547080